Tumor induced osteomalacia: A single center experience on 17 patients.
FGF23
Osteomalacia
Tumor-induced bone disease
Journal
Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
04
03
2021
revised:
21
05
2021
accepted:
16
06
2021
pubmed:
28
6
2021
medline:
10
8
2021
entrez:
27
6
2021
Statut:
ppublish
Résumé
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome due to a phosphaturic tumor, which overproduces Fibroblast Growth Factor 23 (FGF-23), causing hyperphosphaturia, hypophosphatemia, low 1,25(OH)
Identifiants
pubmed: 34175499
pii: S8756-3282(21)00239-8
doi: 10.1016/j.bone.2021.116077
pii:
doi:
Substances chimiques
FGF23 protein, human
0
Fibroblast Growth Factors
62031-54-3
Fibroblast Growth Factor-23
7Q7P4S7RRE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
116077Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.